Spots Global Cancer Trial Database for A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma
Official Title: An Open-label, Single-arm, Multi-center Phase 2 Study to Evaluate the Efficacy and Safety of Oral Histone Deacetylase (HDAC)-Inhibitor Abexinostat, as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma (FL)
Study ID: NCT03934567
Conditions
Interventions
Study Description
Brief Summary: An open-label, single-arm, multi-center phase 2 study to evaluate the efficacy and safety of oral histone deacetylase (HDAC)-inhibitor abexinostat, as monotherapy in patients with relapsed or refractory follicular lymphoma (FL)
Detailed Description: This is an open-label, single-arm, two-stage, multi-center, phase 2 study in patients with relapsed/refractory follicular lymphoma (FL) who have received at least two prior standard therapy lines.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, , China
China-Japan Friendship Hospital, Beijing, , China
Peking University Third Hospital, Beijing, , China
Jilin Cancer Hospital, Changchun, , China
West China Hospital, Sichuan University, Chengdu, , China
The First Affiliated Hospital of Dalian Medical University, Dalian, , China
Fujian Medical University Union Hospital, Fuzhou, , China
Cancer Center of Guangzhou Medical University, Guangzhou, , China
Sun Yai-Sen Memorial Hospital, Sun Yai-Sen University, Guangzhou, , China
Nanfang Hospital, Guangzhou, , China
Hainan General Hospital, Hainan, , China
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, , China
Sir Run Run Shaw Hospital, Zhejiang University School of Medical, Hangzhou, , China
Zhejiang Cancer Hospital, Hangzhou, , China
The Affiliated Tumor Hospital of Harbin Medical University, Harbin, , China
The First Hospital of Lanzhou University, Lanzhou, , China
Linyi Cancer Hospital, Linyi, , China
Nantong Tumor Hospital, Nantong, , China
Shanghai Sixth people's hospital, Shanghai, , China
Fudan University Shanghai Cancer Center, Shanghai, , China
The Forth Hospital of Hebei Medical University, Shijiazhuang, , China
Tianjin People's Hospital, Tianjin, , China
Tianjin Medical University General Hospital, Tianjin, , China
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, , China
Henan Cancer Hospital, Zhengzhou, , China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, , China
Contact Details
Name: Yuankai SHI, Prof
Affiliation: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
